help.medscape.com Oct 30
Stroke neurologists worldwide are evaluating FXIa inhibitors for secondary prevention. Join them—access expert-led CME on our ACE page. mdsc.pe
Story Details
| Last Updated | |
| Total Articles | 5 |
Main Topics
News on this topic
Stroke neurologists worldwide are evaluating FXIa inhibitors for secondary prevention. Join them—access expert-led CME on our ACE page. mdsc.pe
Similar to This
Previous
Stroke: How to recognize that it's serious, and what those affected need to do
echo-online.de/lokales/kreis-bergstrasse/heppenheim-bergstrasse/was-tun-bei-schlaganfall-wie-man-erkennt-dass-es-ernst-ist-6565437
help.medscape.com Aug 31
A Candid Talk on IgA Nephropathy and B Cell Misfires: What really drives IgAN? Go upstream to the mucosal immune system and B-cell signals to discover new ...
medscape.org/viewarticle/candid-talk-iga-nephropathy-and-b-cell-misfires-2026a1000rsi
Bayer: Asundexian impresses in study and becomes a beacon of hope: In a new stroke study, Bayer is impressing with a drug that caused the company a significant ...
faz.net/aktuell/wirtschaft/unternehmen/bayer-asundexian-ueberzeugt-in-studie-und-wird-hoffnungstraeger-110790576.html
Next